Nationwide study of Escherichia coli and Klebsiella pneumoniae producing extended-spectrum beta-lactamases in Spain

Antimicrob Agents Chemother. 2005 May;49(5):2122-5. doi: 10.1128/AAC.49.5.2122-2125.2005.

Abstract

Clonal dissemination of extended-spectrum beta-lactamases (ESBL) in 170 Escherichia coli isolates and 70 Klebsiella pneumoniae isolates from a nationwide study of 40 Spanish centers in 2000 was not observed in most centers. The most prevalent ESBL were CTX-M-9 (27.3%), SHV-12 (23.9%), and CTX-M-14 (20.5%) for E. coli and TEM-3 (16.7%) and TEM-4 (25%) for K. pneumoniae. A new ESBL, TEM-133, with mutations L21F, E104K, and R164S, was identified.

MeSH terms

  • Anti-Infective Agents / pharmacology
  • Conjugation, Genetic
  • Drug Resistance, Bacterial
  • Escherichia coli / drug effects
  • Escherichia coli / enzymology*
  • Escherichia coli Infections / drug therapy
  • Escherichia coli Infections / epidemiology*
  • Escherichia coli Infections / microbiology*
  • Humans
  • Klebsiella Infections / epidemiology*
  • Klebsiella Infections / microbiology*
  • Klebsiella pneumoniae / enzymology*
  • Microbial Sensitivity Tests
  • Molecular Sequence Data
  • Reverse Transcriptase Polymerase Chain Reaction
  • Spain / epidemiology
  • beta-Lactamases / metabolism*

Substances

  • Anti-Infective Agents
  • beta-Lactamases